A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington's Disease (HART)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Teva Pharmaceutical Industries

ClinicalTrials.gov Identifier:

NCT00724048

First received: July 24, 2008

Last updated: July 20, 2016

Last verified: July 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2011
Primary Completion Date:	June 2011 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	February 19, 2013